Table 1 Baseline characteristics and comparison by follow up status
From: Predictors of outcome in early onset schizophrenia: a 10-year follow-up study
Variable | All Participants (N = 118) | Interviewed Group (N = 65) | Non-interviewed Group (N = 53) | p |
|---|---|---|---|---|
Female, % | 50% | 49% | 51% | 0.85 |
Age at onset, y (SD, range) | ||||
 Any symptoms | 13.7 (2.3, 7.1 to 17.7) | 14.0 (2.2, 7.1 to 17.7) | 13.4 (2.3, 7.1 to 16.8) | 0.19 |
 Psychiatric symptoms | 14.4 (2.1, 7.7 to 17.8) | 14.8 (2.2, 8.2 to 17.8) | 14.1 (2.1, 7.7 to 16.9) | 0.18 |
Number of VEOS, n (%) | 39 (34%) | 18 (29%) | 21 (40%) | 0.21 |
Urban residence, % | 71% | 67% | 75% | 0.36 |
Positive family history, % | 30% | 29% | 30% | 0.91 |
Presence of and comorbidity, % | 9% | 9% | 9% | 0.97 |
 Comorbid ADHD, % | 4% | 5% | 4% | 0.82 |
 Comorbid Tourette’s syndrome, % | 3% | 2% | 4% | 0.45 |
 Comorbid other tic disorders, % | 1% | 2% | 0% | 0.37 |
 Comorbid intellectual disabilities, % | 3% | 5% | 2% | 0.42 |
Presence of personality traitsa, % | ||||
 Extroversion | 22% | 23% | 21% | 0.76 |
 Introverted | 70% | 69% | 72% | 0.73 |
 Unsociable | 42% | 38% | 47% | 0.35 |
 Suspicious | 28% | 26% | 30% | 0.63 |
 Perfectionistic | 20% | 17% | 25% | 0.31 |
Obstinate | 12% | 11% | 13% | 0.68 |
 Gentle | 7% | 6% | 8% | 0.78 |
 Capricious | 8% | 11% | 4% | 0.15 |
Antipsychotic dosage at discharge, olanzapine equivalent dose, mg (SD) | 13.6 (6.9) | 13.7 (6.2) | 13.6 (7.8) | 0.93 |